Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Response to letter regarding article 'Fingolimod effects on left ventricular function in multiple sclerosis'.
Anodal transcranial direct current stimulation of motor cortex does not ameliorate spasticity in multiple sclerosis.
William Austin Sibley, MD (1925-2015).
Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis.
JNK inhibitors as anti-inflammatory and neuroprotective agents.
Thalamic Atrophy is Associated with Development of Clinically Definite Multiple Sclerosis.
Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
Regulation of Experimental Autoimmune Encephalomyelitis by TPL-2 Kinase.
Recruitment of participants to a multiple sclerosis trial: The CombiRx experience.
Factors associated with clinically significant increased walking time in multiple sclerosis: Results of a survival analysis of short-term follow-up data from a clinical database.
KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis.
[Multiple sclerosis, neuromyelitis optica and spasticity: control of specific symptoms and quality of life].
GM-CSF-Neuroantigen Fusion Proteins Reverse Experimental Autoimmune Encephalomyelitis and Mediate Tolerogenic Activity in Adjuvant-Primed Environments: Association with Inflammation-Dependent, Inhibitory Antigen Presentation.
HLA-DRB1*15 influences the development of brain tissue damage in early PPMS.
School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis.
Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.
Laparoscopic implantation of neuromodulators for treating urinary dysfunctions and improving locomotion in multiple sclerosis patients.
Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice.
Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis.
Initial investigation of the blood-brain barrier in MS lesions at 7 tesla.
M. paratuberculosis Heat Shock Protein 65 and Human Diseases: Bridging Infection and Autoimmunity.
Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls.
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.
G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Pages